Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shouming Xu
Clinicopathological Significance of DAPK Promoter Methylation in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Cancer Management and Research
Oncology
Related publications
Prognostic Significance of DAPK Promoter Methylation in Lymphoma: A Meta-Analysis
PLoS ONE
Multidisciplinary
Clinicopathological and Prognostic Significance of Oct-4 Expression in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
The Clinicopathological Significance of hMLH1 Hypermethylation in Non-Small-Cell Lung Cancer: A Meta-Analysis and Literature Review
OncoTargets and Therapy
Oncology
Pharmacology
Clinicopathological Significance and a Potential Drug Target of RARβ In Non-Small-Cell Lung Carcinoma: A Meta-Analysis and a Systematic Review
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Clinicopathological Significance and Potential Drug Target of RUNX3 in Non-Small Cell Lung Cancer: A meta-Analysis
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
A Systematic Review and Meta-Analysis: Association Between MGMT Hypermethylation and the Clinicopathological Characteristics of Non-Small-Cell Lung Carcinoma
Scientific Reports
Multidisciplinary
The Clinicopathological Significance of CDH1 in Gastric Cancer: A Meta-Analysis and Systematic Review
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Prognostic Significance of Immune Cells in Non-Small Cell Lung Cancer: Meta-Analysis
Oncotarget
Oncology
Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
